RxSight, Inc. (RXST) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Rxsight, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.676 Thank you for standing by. At this time, I would like to welcome everyone to the RxSight 00:00:04.676 -- 00:00:08.420 first quarter 2025 earnings conference call. 00:00:08.420 -- 00:00:12.324 All lines have been placed on mute to prevent any background noise. 00:00:12.324 -- 00:00:16.348 After the speaker's remarks, there will be a question and answer session. 00:00:16.348 -- 00:00:20.373 If you would like to ask a question during this time, simply press star followed by the 00:00:20.373 -- 00:00:25.478 number one on your telephone keypad. If you would like to redraw your question, press 00:00:25.478 -- 00:00:31.942 star one again. I would now like to turn the conference over to Oliver Moravcevic, 00:00:31.942 -- 00:00:36.687 Vice President of Investor Relations. Please go ahead, sir. 00:00:36.687 -- 00:00:41.532 Thank you, Operator. Presenting today are RxSight President and Chief Executive Officer, 00:00:41.532 -- 00:00:45.536 Dr. Ron Kurtz, and Chief Financial Officer, Shelley Tunin. 00:00:45.536 -- 00:00:50.241 Earlier today, RxSight released its financial results for the three months ending March 00:00:50.241 -- 00:00:51.822 31, 2025, 00:00:51.822 -- 00:00:56.982 and reiterated its full-year guidance. A copy of the press release is available 00:00:56.982 -- 00:01:01.568 on the company's website. Before we begin, I would like to inform you that comments and 00:01:01.568 -- 00:01:06.054 responses to questions during today's call reflect management's view as of today, May 00:01:06.054 -- 00:01:07.997 7, 2025, 00:01:07.997 -- 00:01:12.743 and will include forward-looking and opinion statements, including predictions, estimates, 00:01:12.743 -- 00:01:15.927 plans, expectations, and other information. 00:01:15.927 -- 00:01:20.413 Ac...